Drug Profile
Hydrocodone/paracetamol/alvimopan
Alternative Names: Alvimopan/hydrocodone/acetaminophen; Alvimopan/hydrocodone/paracetamol; Hydrocodone/acetaminophen/alvimopanLatest Information Update: 14 Dec 2011
Price :
$50
*
At a glance
- Originator Adolor Corporation
- Developer Cubist Pharmaceuticals
- Class Acetanilides; Gastrokinetics; Morphine derivatives; Non-opioid analgesics; Opioid analgesics; Opioid peptides; Piperidines; Small molecules
- Mechanism of Action Opioid mu receptor antagonists; Opioid receptor agonists; Prostaglandin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Suspended Pain
Most Recent Events
- 12 Dec 2011 Adolor Corporation has been acquired and merged into Cubist Pharmaceuticals
- 30 Jun 2006 Phase-II clinical trials in Pain in USA (unspecified route)